{
    "2020-10-14": [
        [
            {
                "time": "",
                "original_text": "华大基因预计上半年净利同比增张逾8倍，主要受新冠疫情影响",
                "features": {
                    "keywords": [
                        "华大基因",
                        "净利",
                        "同比增长",
                        "新冠疫情影响"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "基因检测"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "公告精选丨华大基因：前三季预盈26亿-27.5亿元",
                "features": {
                    "keywords": [
                        "华大基因",
                        "前三季",
                        "预盈",
                        "26亿-27.5亿元"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "基因检测"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华大基因：前三季度预计净利润同比增长862.69%~918.23%",
                "features": {
                    "keywords": [
                        "华大基因",
                        "前三季",
                        "净利润",
                        "同比增长",
                        "862.69%",
                        "918.23%"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "基因检测"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华大基因：前三季净利预增863%-918%",
                "features": {
                    "keywords": [
                        "华大基因",
                        "前三季",
                        "净利",
                        "预增",
                        "863%",
                        "918%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "基因检测"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华大基因：预计前三季盈利26亿-27.5亿元，同比增长862.69%-918.23%",
                "features": {
                    "keywords": [
                        "华大基因",
                        "前三季",
                        "盈利",
                        "26亿-27.5亿元",
                        "同比增长",
                        "862.69%",
                        "918.23%"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "基因检测"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "IVD行业事件点评：三季度新冠业务预期差显着 建议把握投资窗口期",
                "features": {
                    "keywords": [
                        "IVD行业",
                        "新冠业务",
                        "预期差",
                        "投资窗口期"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "体外诊断"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}